Business
Press Release Jan 15 2021
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 15, 2021, titled "Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 15, 2021, titled \"Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets\". View Attachment","length":356,"tagName":"div"}]